Breast Cancer Subtypes in Patients Aged 70 Years and Older

References

• Hery C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 2008;19(6):1187–1194.
   PubMed Web of Science ®Google Scholar
• Owusu C, Hurria A, Muss H. Adjuvant therapy for older women with early-stage breast cancer: treatment selection in a complex population. Amer Soc Clin Oncol Educ Book/Amer Soc Clin Oncol Meeting 2012;3–9.
   Google Scholar
• Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009;360(20):2055–2065.
   PubMed Web of Science ®Google Scholar
• Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003;21(7):1383–1389.
   PubMed Web of Science ®Google Scholar
• Enger SM, Thwin SS, Buist DS, Field T, Frost F, Geiger AM, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol 2006;24(27):4377–4383.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013;24(9):2206–2223.
   PubMed Web of Science ®Google Scholar
• Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009;101(10):736–750.
   PubMed Web of Science ®Google Scholar
• Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10(16):5367–5374.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, et al. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011;22(8):1736–1747.
   PubMed Web of Science ®Google Scholar
• Mandelblatt JS, Faul LA, Luta G, Makgoeng SB, Isaacs C, Taylor K, et al. Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901. J Clin Oncol 2012;30(21):2609–2614.
   PubMed Web of Science ®Google Scholar
• Ring A, Reed M, Leonard R, Kunkler I, Muss H, Wildiers H, et al. The treatment of early breast cancer in women over the age of 70. Brit J Cancer 2011;105(2):189–193.
   PubMed Web of Science ®Google Scholar
• Anderson WF, Katki HA, Rosenberg PS. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 2011;103(18):1397–1402.
   PubMedGoogle Scholar
• Biganzoli L, Wildiers H, Oakman C, Marotti L, Loibl S, Kunkler I, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012;13(4):e148–e160.
   PubMed Web of Science ®Google Scholar
• Taylor WC, Muss HB. Recent advances: adjuvant therapy for older women with breast cancer. Cancer J 2010;16(4):289–293.
   PubMed Web of Science ®Google Scholar
• Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, et al. Do we need HER-2/neu testing for all patients with primary breast carcinoma? Cancer 2003;98(12):2547–2553.
   PubMed Web of Science ®Google Scholar
• Pohl G, Rudas M, Taucher S, Stranzl T, Steger GG, Jakesz R, et al. Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy. Breast Cancer Res Treat 2003;78(1):97–103.
   PubMed Web of Science ®Google Scholar
• Regitnig P, Reiner A, Dinges HP, Hofler G, Muller-Holzner E, Lax SF, et al. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories. Virchow Arch 2002;441(4):328–334.
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 1995;332(14):901–906.
   PubMed Web of Science ®Google Scholar
• Jenkins EO, Deal AM, Anders CK, Prat A, Perou CM, Carey LA, et al. Age-specific changes in intrinsic breast cancer subtypes: a focus on older women. Oncologist 2014;19(10):1076–1083.
   PubMed Web of Science ®Google Scholar
• Konigsberg R, Pfeiler G, Klement T, Hammerschmid N, Brunner A, Zeillinger R, et al. Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients. Eur J Cancer 2012;48(16):2962–2968.
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363(20):1938–1948.
   PubMed Web of Science ®Google Scholar
• Heitz F, Harter P, Lueck HJ, Fissler-Eckhoff A, Lorenz-Salehi F, Scheil-Bertram S, et al. Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. Eur J Cancer 2009;45(16):2792–2798.
   PubMed Web of Science ®Google Scholar
• Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, et al. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 2012;104(14):1094–1101.
   PubMedGoogle Scholar
• Schneider M, Zuckerman IH, Onukwugha E, Pandya N, Seal B, Gardner J, et al. Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis. J Amer Geriat Soc 2011;59(4):637–646.
   PubMed Web of Science ®Google Scholar
• van de Water W, Seynaeve C, Bastiaannet E, Markopoulos C, Jones SE, Rea D, et al. Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. Oncologist 2013;18(1):8–13.
   PubMed Web of Science ®Google Scholar
• Klepin HD, Pitcher BN, Ballman KV, Kornblith AB, Hurria A, Winer EP, et al. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). J Oncol Pract Amer Soc Clin Oncol 2014;10(5):e285–292.
   Google Scholar